Thrombosis and hemostasis are vital processes preserving vascular health, with disruptions leading to debilitating and life-threatening disorders such as ...
The ALBORADA Drug Discovery Institute, University of Cambridge, Cambridge, United Kingdom ...
The study aimed to assess the prevalence and characteristics of potential drug-drug interactions (pDDIs) that increase the risk of QT prolongation, in a population of cardiovascular disease patients.
Boston, MA – June 12, 2025 — Receptor.AI, a leading AI-driven drug discovery company, today announced the incorporation of the REAXENSE TM platform, developed by Reaxense Inc., a Canadian chemical and ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Intrinsically disordered proteins are implicated in many human diseases. Small ...
Neurotrophin (NT) receptor signaling regulates neuronal survival, axonal and dendritic network maintenance, differentiation, and synaptic plasticity. Signaling is initiated by binding of NT to the ...
GPCRs (G protein-coupled receptors), also known as 7 transmembrane domain receptors, are the largest receptor family in the human genome, with ≈800 members. GPCRs regulate nearly every aspect of human ...
Abstract: Artificial intelligence techniques play a pivotal role in the accurate identification of drug-drug interaction (DDI) events, thereby informing clinical decisions and treatment regimens.
Dextromethorphan (Delsym, Robitussin) can interact with alcohol, other medications, and some supplements. For example, dextromethorphan can interact with selective serotonin reuptake inhibitors (SSRIs ...
In a live event, Ganesh V. Raj, MD, PhD, discussed the drug-drug interactions and outcomes by disease volumes across ARPI trials in mHSPC. Targeted Oncology: Could you highlight practical ...
This work presents an important technological advance, in the form of a high throughput platform for Single Particle Tracking allowing us to measure millions of cells and thousands of compounds per ...